Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials

scientific article

Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0001752
P932PMC publication ID3459884
P698PubMed publication ID23029567
P5875ResearchGate publication ID231815911

P50authorJeremy FarrarQ15967402
Paul R YoungQ54435348
Pei-Yong ShiQ59435668
Marcel WolbersQ59593777
Rosemary PetricQ99253511
Bridget WillsQ30112202
Cameron P. SimmonsQ37392993
P2093author name stringVan Vinh Chau Nguyen
Jamie Whitehorn
Minh Nguyet Nguyen
P2860cites workComparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responsesQ21261839
DengueQ24570132
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severityQ27860703
A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adultsQ28475036
Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengueQ28476805
DengueQ29619772
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infectionsQ33342343
Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trialQ33402687
Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmissionQ33926902
A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patientsQ34288828
Heart rate variability: a diagnostic and prognostic tool in anesthesia and intensive care.Q37887033
Physiological abnormalities in early warning scores are related to mortality in adult inpatients.Q47997987
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectDengue virusQ476209
P304page(s)e1752
P577publication date2012-09-27
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titleTherapeutics for dengue: recommendations for design and conduct of early-phase clinical trials
P478volume6

Reverse relations

cites work (P2860)
Q39307353A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening
Q35577798A Prognostic Model for Development of Profound Shock among Children Presenting with Dengue Shock Syndrome
Q114704050A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
Q85327578Dengue
Q39590469Dengue human infection models supporting drug development
Q28542607Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions
Q47561665Dengue virus induced changes in Ca2+ homeostasis in human hepatic cells that favor the viral replicative cycle.
Q40246811Dengue virus: two hosts, two structures
Q36895627Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes
Q34261488Inhibition of enterovirus 71 by adenosine analog NITD008
Q38096721Intervention strategies for emerging viruses: use of antivirals
Q38056781Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
Q89992595Paracetamol for dengue fever: no benefit and potential harm?
Q35250382Sensitivity and specificity of a novel classifier for the early diagnosis of dengue
Q34464403Small molecules with antiviral activity against the Ebola virus
Q26700120Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
Q38947779Within-host viral dynamics of dengue serotype 1 infection

Search more.